We are excited to announce that the repository will soon undergo an upgrade, featuring a new look and feel along with several enhanced features to improve your experience. Please be on the lookout for further updates and announcements regarding the launch date. We appreciate your support and look forward to unveiling the improved platform soon.
dc.contributor.author | Coetzee, Peter![]() |
|
dc.contributor.author | Stokstad, Maria![]() |
|
dc.contributor.author | Venter, Estelle Hildegard![]() |
|
dc.contributor.author | Myrmel, Mette![]() |
|
dc.contributor.author | Van Vuuren, Moritz![]() |
|
dc.date.accessioned | 2012-11-30T08:06:49Z | |
dc.date.available | 2012-11-30T08:06:49Z | |
dc.date.issued | 2012-09-13 | |
dc.description.abstract | Bluetongue (BT) is a non-contagious, infectious, arthropod transmitted viral disease of domestic and wild ruminants that is caused by the bluetongue virus (BTV), the prototype member of the Orbivirus genus in the family Reoviridae. Bluetongue was first described in South Africa, where it has probably been endemic in wild ruminants since antiquity. Since its discovery BT has had a major impact on sheep breeders in the country and has therefore been a key focus of research at the Onderstepoort Veterinary Research Institute in Pretoria, South Africa. Several key discoveries were made at this Institute, including the demonstration that the aetiological agent of BT was a dsRNA virus that is transmitted by Culicoides midges and that multiple BTV serotypes circulate in nature. It is currently recognized that BT is endemic throughout most of South Africa and 22 of the 26 known serotypes have been detected in the region. Multiple serotypes circulate each vector season with the occurrence of different serotypes depending largely on herd-immunity. Indigenous sheep breeds, cattle and wild ruminants are frequently infected but rarely demonstrate clinical signs, whereas improved European sheep breeds are most susceptible. The immunization of susceptible sheep remains the most effective and practical control measure against BT. In order to protect sheep against multiple circulating serotypes, three pentavalent attenuated vaccines have been developed. Despite the proven efficacy of these vaccines in protecting sheep against the disease, several disadvantages are associated with their use in the field. | en |
dc.description.librarian | ab2012 | en |
dc.description.sponsorship | The Norwegian School of Veterinary Science | en |
dc.description.uri | http://www.virologyj.com/content/9/1/198 | en |
dc.identifier.citation | Coetzee et al.: Bluetongue: a historical and epidemiological perspective with the emphasis on South Africa. Virology Journal 2012 9:198. | en |
dc.identifier.issn | 1743-422X (print) | |
dc.identifier.issn | 1743-422X (online) | |
dc.identifier.other | 10.1186/1743-422X-9-198 | |
dc.identifier.other | 7003904650 | |
dc.identifier.other | 7004572625 | |
dc.identifier.other | O-6953-2014 | |
dc.identifier.other | N-9080-2014 | |
dc.identifier.uri | http://hdl.handle.net/2263/20611 | |
dc.language.iso | en | en |
dc.publisher | BioMed Central | en |
dc.relation.requires | Adobe Acrobat Reader | en |
dc.rights | © 2012 Coetzee et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License | en |
dc.subject | Bluetongue virus | en |
dc.subject | Culicoides | en |
dc.subject | Serotype | en |
dc.subject | Survey | en |
dc.subject | African carnivores | en |
dc.subject | African herbivores | en |
dc.subject | Sheep -- Diseases | en |
dc.subject | Cattle -- Diseases | en |
dc.subject | Onderstepoort | en |
dc.subject | South Africa | en |
dc.subject | Vaccines | en |
dc.subject.lcsh | Bluetongue -- South Africa | en |
dc.subject.lcsh | Orbivirus infections in animals -- South Africa | en |
dc.subject.lcsh | Veterinary epidemiology -- South Africa | en |
dc.subject.lcsh | Bluetongue -- Epidemiology | en |
dc.title | Bluetongue : a historical and epidemiological perspective with the emphasis on South Africa | en |
dc.type | Article | en |